Kari Høeg

683 total citations
27 papers, 548 citations indexed

About

Kari Høeg is a scholar working on Epidemiology, Oncology and Reproductive Medicine. According to data from OpenAlex, Kari Høeg has authored 27 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Oncology and 7 papers in Reproductive Medicine. Recurrent topics in Kari Høeg's work include Ovarian cancer diagnosis and treatment (7 papers), Cervical Cancer and HPV Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Kari Høeg is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Cervical Cancer and HPV Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Kari Høeg collaborates with scholars based in Norway, United States and United Kingdom. Kari Høeg's co-authors include Per Kolstad, J. Chr. Aure, Bjarne Hager, John H. Crosby, Einar Pedersen, Margaret Davy, A Engeset, Eduard E. de Lange, E.H. Cooper and Herman Høst and has published in prestigious journals such as Blood, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Kari Høeg

27 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Høeg Norway 11 334 148 124 105 101 27 548
Claes Tropé Norway 10 307 0.9× 197 1.3× 116 0.9× 76 0.7× 48 0.5× 13 443
Richard L. Voet United States 12 106 0.3× 107 0.7× 136 1.1× 128 1.2× 147 1.5× 25 513
Nieberg Rk United States 8 593 1.8× 373 2.5× 244 2.0× 91 0.9× 81 0.8× 9 710
John G. Boutselis United States 18 259 0.8× 393 2.7× 200 1.6× 142 1.4× 48 0.5× 36 694
D. Ian Robertson Canada 13 221 0.7× 215 1.5× 176 1.4× 76 0.7× 40 0.4× 26 533
Mary C. Bibro United States 12 129 0.4× 151 1.0× 174 1.4× 54 0.5× 60 0.6× 19 464
Robert E. Girtanner United States 11 169 0.5× 300 2.0× 236 1.9× 153 1.5× 58 0.6× 26 601
Charles Whitney United States 10 483 1.4× 354 2.4× 199 1.6× 119 1.1× 164 1.6× 12 743
Fredric V. Price United States 15 342 1.0× 377 2.5× 99 0.8× 162 1.5× 43 0.4× 32 677
Ryuichiro Tsunematsu Japan 14 277 0.8× 310 2.1× 227 1.8× 156 1.5× 56 0.6× 26 639

Countries citing papers authored by Kari Høeg

Since Specialization
Citations

This map shows the geographic impact of Kari Høeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Høeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Høeg more than expected).

Fields of papers citing papers by Kari Høeg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Høeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Høeg. The network helps show where Kari Høeg may publish in the future.

Co-authorship network of co-authors of Kari Høeg

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Høeg. A scholar is included among the top collaborators of Kari Høeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Høeg. Kari Høeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crosby, John H., Kari Høeg, & Bjarne Hager. (1985). Transthoracic fine needle aspiration of primary and metastatic sarcomas. Diagnostic Cytopathology. 1(3). 221–227. 8 indexed citations
2.
Berner, A., et al.. (1980). Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.. PubMed. 2(2). 99–101. 1 indexed citations
3.
Kolstad, Per, Margaret Davy, & Kari Høeg. (1977). Individualized treatment of ovarian cancer. American Journal of Obstetrics and Gynecology. 128(6). 617–625. 28 indexed citations
4.
Roger, Roger, et al.. (1973). Tumor cells in blood: the prognostic significance of tumor cells in blood during palpation and biopsy.. PubMed. 16(6). 557–60. 5 indexed citations
5.
Høeg, Kari, et al.. (1972). The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report.. PubMed. 16(3). 269–72. 6 indexed citations
6.
Kolstad, Per, Kari Høeg, & Nils Norman. (1972). Malignant Trophoblastic Neoplasia. Acta Obstetricia Et Gynecologica Scandinavica. 51(3). 275–281. 4 indexed citations
7.
Aure, J. Chr., Kari Høeg, & Per Kolstad. (1971). Radioactive Colloidal Gold in the Treatment of Ovarian Carcinoma. Acta Radiologica Therapy Physics Biology. 10(4). 399–407. 11 indexed citations
8.
Engeset, A, et al.. (1971). The thoracic duct lymph in Hodgkin's disease. II. Quantitative analysis of the cellular composition of the lymph. International Journal of Cancer. 8(1). 113–121. 16 indexed citations
9.
Aure, J. Chr., Kari Høeg, & Per Kolstad. (1971). Carcinoma of the Ovary and Endometriosis. Acta Obstetricia Et Gynecologica Scandinavica. 50(1). 63–67. 44 indexed citations
10.
Aure, J. Chr., Kari Høeg, & Per Kolstad. (1971). Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases.. PubMed. 37(1). 1–9. 218 indexed citations
11.
Pedersen, Einar, Kari Høeg, & Per Kolstad. (1971). Mass Screening for Cancer of the Uterine Cervix in Østfold County, Norway: An Experiment. Acta Obstetricia Et Gynecologica Scandinavica. 50(1). 69–71. 3 indexed citations
12.
Pedersen, Einar, Kari Høeg, & Per Kolstad. (1971). Mass Screening for Cancer of the Uterine Cervix in Østfold County, Norway: An Experiment Second Report of the Norwegian Cancer Society. Acta Obstetricia Et Gynecologica Scandinavica. 50(S11). 1–18. 25 indexed citations
13.
Høeg, Kari, et al.. (1970). [Ovarian neoplasms. A retrospective study of 990 cases].. PubMed. 84(46). 1470–1. 6 indexed citations
14.
Engeset, A, et al.. (1969). Thoracic duct lymph cytology in Hodgkin's disease. International Journal of Cancer. 4(5). 735–742. 8 indexed citations
15.
Engeset, A, et al.. (1968). Sternberg-Reed Cells in the Thoracic Duct Lymph of Patients with Hodgkin’s Disease. Blood. 31(1). 99–103. 16 indexed citations
16.
Høeg, Kari, et al.. (1968). Dysplasia, Carcinoma in Situ, and Invasive Carcinoma of the Cervix Uteri in Previously Screened Women. Scandinavian Journal of Clinical and Laboratory Investigation. 21(sup106). 173–180. 3 indexed citations
17.
Høeg, Kari, et al.. (1968). Dysplasia, Carcinoma in Situ, and Invasive Carcinoma of the Cervix Uteri in Previously Screened Women. Scandinavian Journal of Clinical and Laboratory Investigation. 21. 173–180. 2 indexed citations
18.
Høeg, Kari, et al.. (1967). Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.. PubMed. 11(1). 39–40. 4 indexed citations
19.
Høeg, Kari. (1959). OSTEOBLASTIC MENINGIOMA. Acta Pathologica Microbiologica Scandinavica. 46(1). 43–46. 2 indexed citations
20.
Høeg, Kari. (1956). SUPERFICIAL DISSEMINATION OF CANCER OF THE UTERINE BODY. CYTOLOGICAL EXAMINATION OF SMEARS FROM THE TUBES AND THE POUCH OF DOUGLAS. BJOG An International Journal of Obstetrics & Gynaecology. 63(6). 899–902. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026